It has been estimated that male carriers of an MMR mutation have a 74% lifetime risk of developing colorectal cancer compared to 30% in females, who also have a 42% risk of endometrial cancer (Dunlop et al, 1997). This evidence concerns the gene MRC1 and colorectal cancer.